Anti-myoglobin antibody liposomes leverage the specificity of antibodies to improve drug delivery systems, ensuring that therapeutic agents are directed to cells or tissues that express myoglobin. By conjugating anti-myoglobin antibodies to the surface of liposomes, these nano-carriers can effectively bind to their target cells, resulting in a more precise and efficient therapeutic response while minimizing side effects. This innovative approach not only enhances the bioavailability of the drugs but also holds the potential for improved outcomes in treating conditions associated with myoglobin, such as muscle-related disorders or injuries.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0228-YC-S(P) | Human Anti-Myosin Recombinant Antibody (clone SF9); scFv Fragment | ELISA, IF, WB | Human scFv |
HPAB-2028-FY-S(P) | Human Anti-Myosin Recombinant Antibody (clone B1F8B5); scFv Fragment | WB, ELISA | Human scFv |
HPAB-2029-FY-S(P) | Human Anti-Myosin Recombinant Antibody scFv Fragment (HPAB-2029-FY-S(P)) | WB, ELISA | Human scFv |
HPAB-2030-FY-S(P) | Human Anti-Myosin Recombinant Antibody (clone B2E9D5); scFv Fragment | WB, ELISA | Human scFv |
There are currently no Customer reviews or questions for VS-1024-FY203. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.